| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 26.099 | 33.743 | 35.863 | 29.528 | 31.928 | 37.701 | 105.001 | 96.125 | 73.797 | 59.857 |
| Total Income - EUR | 26.779 | 34.412 | 35.865 | 29.528 | 31.928 | 37.701 | 105.144 | 97.963 | 74.662 | 59.865 |
| Total Expenses - EUR | 20.908 | 32.628 | 29.236 | 28.104 | 30.535 | 34.037 | 57.221 | 90.779 | 84.208 | 61.871 |
| Gross Profit/Loss - EUR | 5.871 | 1.785 | 6.629 | 1.424 | 1.393 | 3.664 | 47.923 | 7.184 | -9.546 | -2.006 |
| Net Profit/Loss - EUR | 5.089 | 1.444 | 6.274 | 1.129 | 1.074 | 3.444 | 46.965 | 6.479 | -10.284 | -2.605 |
| Employees | 2 | 3 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 1 |
Check the financial reports for the company - Lin-Md Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 34 | 0 | 486 | 334 | 187 | 802 | 698 | 3.553 | 1.458 | 2.078 |
| Current Assets | 6.211 | 7.491 | 13.386 | 5.058 | 6.239 | 6.600 | 51.733 | 15.815 | 12.291 | 11.129 |
| Inventories | 1.288 | 2.214 | 2.317 | 2.302 | 1.882 | 1.501 | 224 | 9.412 | 7.210 | 5.668 |
| Receivables | 4.388 | 4.834 | 5.822 | 967 | 948 | 1.923 | 18.187 | 4.620 | 2.288 | 1.888 |
| Cash | 535 | 443 | 5.247 | 1.789 | 3.409 | 3.176 | 33.322 | 1.783 | 2.793 | 3.574 |
| Shareholders Funds | 5.134 | 6.526 | 12.690 | 1.181 | 2.232 | 5.634 | 48.734 | 6.528 | -3.776 | -6.359 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.111 | 965 | 1.183 | 4.211 | 4.194 | 1.768 | 3.697 | 12.841 | 17.526 | 19.566 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4759 - 4759" | |||||||||
| CAEN Financial Year |
4759
|
|||||||||
Comments - Lin-Md Srl